FDA Warns Sanofi of Manufacturing Irregularities at Key Facility

THURSDAY, Jan. 23, 2025-- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients at their Genzyme manufacturing...